Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription

Articles published in BMC Cancer

Retrieve available abstracts of 122 articles:
HTML format

Single Articles

    November 2022
  1. LI Y, Jia M, Cao L, Yu J, et al
    Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
    BMC Cancer. 2022;22:1172.
    PubMed     Abstract available

  2. QIN X, Wang C, Gong G, Wang L, et al
    Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer.
    BMC Cancer. 2022;22:1149.
    PubMed     Abstract available

  3. DU Y, Geng G, Zhao C, Gao T, et al
    LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
    BMC Cancer. 2022;22:1145.
    PubMed     Abstract available

    October 2022
  4. MPACHIKA-MFIPA F, Kululanga LI, Kazembe A, Mfipa D, et al
    Socio-demographic determinants of cervical cancer screening uptake among women of child-bearing age in Mangochi, Malawi: a facility-based cross-sectional study.
    BMC Cancer. 2022;22:1096.
    PubMed     Abstract available

  5. VIKRAMDEO KS, Anand S, Pierce JY, Singh AP, et al
    Distribution of microbiota in cervical preneoplasia of racially disparate populations.
    BMC Cancer. 2022;22:1074.
    PubMed     Abstract available

  6. BRUNO MT, Cassaro N, Mazza G, Guaita A, et al
    Spontaneous regression of cervical intraepithelial neoplasia 3 in women with a biopsy-cone interval of greater than 11 weeks.
    BMC Cancer. 2022;22:1072.
    PubMed     Abstract available

  7. ZHANG J, Dong D, Wei Q, Ren L, et al
    CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
    BMC Cancer. 2022;22:1052.
    PubMed     Abstract available

  8. CHEN H, Gu L, Zhang M, Chen H, et al
    Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
    BMC Cancer. 2022;22:1039.
    PubMed     Abstract available

    September 2022
  9. KARPINETS TV, Wu X, Solley T, El Alam MB, et al
    Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.
    BMC Cancer. 2022;22:945.
    PubMed     Abstract available

    August 2022
  10. DORJI N, Tshering S, Choden S, Chhetri M, et al
    Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+).
    BMC Cancer. 2022;22:930.
    PubMed     Abstract available

  11. GLASMEYER L, Mcharo RD, Torres L, Lennemann T, et al
    Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    BMC Cancer. 2022;22:892.
    PubMed     Abstract available

  12. LI M, Xiao Y, Liu M, Ning Q, et al
    MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.
    BMC Cancer. 2022;22:876.
    PubMed     Abstract available

  13. NASCIMENTO NPG, Gally TB, Borges GF, Campos LCG, et al
    Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
    BMC Cancer. 2022;22:862.
    PubMed     Abstract available

  14. TIITI TA, Selabe SG, Bogers J, Lebelo RL, et al
    High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    BMC Cancer. 2022;22:854.
    PubMed     Abstract available

    July 2022
  15. MARTINEZ A, Chantalat E, Angeles MA, Ferron G, et al
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    BMC Cancer. 2022;22:810.
    PubMed     Abstract available

  16. CHEN J, Li C, Cao Y, Zhu L, et al
    Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
    BMC Cancer. 2022;22:793.
    PubMed     Abstract available

  17. HE Z, Chen R, Hu S, Zhang Y, et al
    The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
    BMC Cancer. 2022;22:776.
    PubMed     Abstract available

  18. SINGH G, Sharma SK, Singh SK
    miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
    BMC Cancer. 2022;22:777.
    PubMed     Abstract available

    June 2022
  19. MAN X, Yang X, Wei Z, Tan Y, et al
    High expression level of CXCL1/GROalpha is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.
    BMC Cancer. 2022;22:712.
    PubMed     Abstract available

  20. PAN B, Wan T, Jiang Y, Zheng X, et al
    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
    BMC Cancer. 2022;22:655.
    PubMed     Abstract available

  21. ZHANG W, Cao H, Yang J, Zhao J, et al
    The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
    BMC Cancer. 2022;22:636.
    PubMed     Abstract available

  22. HWANG WY, Chang SJ, Kim HS, Kim NK, et al
    Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators
    BMC Cancer. 2022;22:603.
    PubMed     Abstract available

    May 2022
  23. CAO HZ, Yang WT, Zheng PS
    Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    BMC Cancer. 2022;22:521.
    PubMed     Abstract available

  24. JUDAH G, Dilib F, Darzi A, Huf S, et al
    A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance.
    BMC Cancer. 2022;22:522.
    PubMed     Abstract available

  25. CHEN R, Gan Q, Zhao S, Zhang D, et al
    DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    BMC Cancer. 2022;22:488.
    PubMed     Abstract available

  26. BENIDER A, Bendahhou K, Sauvaget C, Mrabti H, et al
    Evolution of patterns of care for women with cervical cancer in Morocco over a decade.
    BMC Cancer. 2022;22:479.
    PubMed     Abstract available

    April 2022
  27. HEMMINKI K, Kanerva A, Forsti A, Hemminki A, et al
    Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
    BMC Cancer. 2022;22:456.
    PubMed     Abstract available

  28. LI K, Xu H, Wang S, Qin P, et al
    Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.
    BMC Cancer. 2022;22:419.
    PubMed     Abstract available

  29. HE Y, Han SB, Liu Y, Zhang JJ, et al
    Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    BMC Cancer. 2022;22:411.
    PubMed     Abstract available

  30. GALLARDO-ALVARADO L, Cantu-de Leon D, Ramirez-Morales R, Santiago-Concha G, et al
    Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.
    BMC Cancer. 2022;22:401.
    PubMed     Abstract available

  31. WEI B, Zhang B, Xue P, Seery S, et al
    Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.
    BMC Cancer. 2022;22:388.
    PubMed     Abstract available

  32. WU X, Feng H, Gao S, Feng H, et al
    A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.
    BMC Cancer. 2022;22:384.
    PubMed     Abstract available

  33. HOLMQVIST A, Lindahl G, Mikivier R, Uppungunduri S, et al
    Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients.
    BMC Cancer. 2022;22:371.
    PubMed     Abstract available

  34. CHEN L, Qing J, Xiao Y, Huang X, et al
    TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    BMC Cancer. 2022;22:370.
    PubMed     Abstract available

  35. WANG H, Jiang Y, Liang Y, Wei L, et al
    Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2022;22:362.
    PubMed     Abstract available

    March 2022
  36. PARK SJ, Kong TW, Kim T, Lee M, et al
    Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial prot
    BMC Cancer. 2022;22:331.
    PubMed     Abstract available

  37. MKUU RS, Staras SA, Szurek SM, D'Ingeo D, et al
    Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.
    BMC Cancer. 2022;22:252.
    PubMed     Abstract available

    February 2022
  38. ZHANG H, Yu R, Zhang L, Wang R, et al
    Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    BMC Cancer. 2022;22:202.
    PubMed     Abstract available

  39. LIU W, Jiang Q, Sun C, Liu S, et al
    Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
    BMC Cancer. 2022;22:192.
    PubMed     Abstract available

  40. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
    Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA.
    BMC Cancer. 2022;22:164.
    PubMed     Abstract available

  41. SINGH M, Jha RP, Shri N, Bhattacharyya K, et al
    Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.
    BMC Cancer. 2022;22:149.
    PubMed     Abstract available

  42. FISCHER S, Kuebler U, Abbruzzese E, Breymann C, et al
    Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence.
    BMC Cancer. 2022;22:145.
    PubMed     Abstract available

  43. METAXAS T, Kenfack B, Sormani J, Tincho E, et al
    Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
    BMC Cancer. 2022;22:132.
    PubMed     Abstract available

    January 2022
  44. REN J, Li L, Yu B, Xu E, et al
    Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.
    BMC Cancer. 2022;22:88.
    PubMed     Abstract available

  45. HOU M, Song K, Ren J, Wang K, et al
    Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
    BMC Cancer. 2022;22:87.
    PubMed     Abstract available

  46. SONG F, Yan P, Huang X, Wang C, et al
    Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    BMC Cancer. 2022;22:42.
    PubMed     Abstract available

  47. JIANG AG, Cai X
    Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    BMC Cancer. 2022;22:4.
    PubMed     Abstract available

    November 2021
  48. DENG Q, Long Q, Liu Y, Yang Z, et al
    Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
    BMC Cancer. 2021;21:1282.
    PubMed     Abstract available

  49. KIM SI, Kim JY, Wee CW, Lee M, et al
    Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
    BMC Cancer. 2021;21:1260.
    PubMed     Abstract available

  50. CHEN L, Lin L, Li L, Xie Z, et al
    Lymphatic leakage after pelvic lymphadenectomy for cervical cancer: a retrospective case-control study.
    BMC Cancer. 2021;21:1242.
    PubMed     Abstract available

  51. YANG P, Ruan Y, Yan Z, Gao Y, et al
    Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    BMC Cancer. 2021;21:1230.
    PubMed     Abstract available

    October 2021
  52. ZHAO M, Pu X, Yan YJ, Zhang S, et al
    The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China.
    BMC Cancer. 2021;21:1110.
    PubMed     Abstract available

  53. DERESSA BT, Assefa M, Tafesse E, Kantelhardt EJ, et al
    Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.
    BMC Cancer. 2021;21:1102.
    PubMed     Abstract available

  54. CHEN L, Niu Y, Wan X, Yu L, et al
    Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
    BMC Cancer. 2021;21:1095.
    PubMed     Abstract available

  55. CHEN C, Duan H, Zhang W, Zhao H, et al
    Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
    BMC Cancer. 2021;21:1091.
    PubMed     Abstract available

  56. SIMSONE Z, Freivalds T, Bema D, Mikelsone I, et al
    Cancer microcell initiation and determination.
    BMC Cancer. 2021;21:1087.
    PubMed     Abstract available

  57. CHENG J, Liu B, Wang B, Long X, et al
    Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
    BMC Cancer. 2021;21:1078.
    PubMed     Abstract available

    September 2021
  58. COQUAN E, Brachet PE, Licaj I, Leconte A, et al
    CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
    BMC Cancer. 2021;21:1054.
    PubMed     Abstract available

  59. KAWAMURA M, Koide Y, Murai T, Ishihara S, et al
    The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    BMC Cancer. 2021;21:1046.
    PubMed     Abstract available

  60. DESTAW A, Midaksa M, Addissie A, Kantelhardt EJ, et al
    Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia.
    BMC Cancer. 2021;21:1031.
    PubMed     Abstract available

  61. YANG J, Yan Z, Wang Y, Xu J, et al
    Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    BMC Cancer. 2021;21:997.
    PubMed     Abstract available

    August 2021
  62. LIU J, Liu X, Guo Z, Lv X, et al
    Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making.
    BMC Cancer. 2021;21:964.
    PubMed     Abstract available

  63. BONI SP, Gnahatin F, Comoe JC, Tchounga B, et al
    Barriers and facilitators in cervical cancer screening uptake in Abidjan, Cote d'Ivoire in 2018: a cross-sectional study.
    BMC Cancer. 2021;21:952.
    PubMed     Abstract available

  64. ZHONG G, Wang Y, Xie Q, Lin R, et al
    HPV-specific risk assessment of cervical cytological abnormalities.
    BMC Cancer. 2021;21:949.
    PubMed     Abstract available

  65. HANSEN BT, Campbell S, Nygard M
    Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
    BMC Cancer. 2021;21:935.
    PubMed     Abstract available

  66. WU B, Xi S
    Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    BMC Cancer. 2021;21:928.
    PubMed     Abstract available

    July 2021
  67. KIM JY, Lee DW, Kim MJ, Shin JE, et al
    Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).
    BMC Cancer. 2021;21:880.
    PubMed     Abstract available

  68. LI X, Xu C, Yu Y, Guo Y, et al
    Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    BMC Cancer. 2021;21:866.
    PubMed     Abstract available

  69. QI J, Zhou L, Li D, Yang J, et al
    Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.
    BMC Cancer. 2021;21:819.
    PubMed     Abstract available

  70. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:811.

  71. LI Y, Luo H, Zhang X, Chang J, et al
    Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions.
    BMC Cancer. 2021;21:804.
    PubMed     Abstract available

  72. DAI MZ, Qiu Y, Di XH, Shi WW, et al
    Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.
    BMC Cancer. 2021;21:769.
    PubMed     Abstract available

    June 2021
  73. WU B, Xi S
    Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    BMC Cancer. 2021;21:733.
    PubMed     Abstract available

  74. JIANG P, Cao Y, Gao F, Sun W, et al
    SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
    BMC Cancer. 2021;21:694.
    PubMed     Abstract available

  75. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:682.
    PubMed     Abstract available

  76. ZHAO J, Cao H, Zhang W, Fan Y, et al
    SOX14 hypermethylation as a tumour biomarker in cervical cancer.
    BMC Cancer. 2021;21:675.
    PubMed     Abstract available

  77. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
    Assessing service availability and readiness to manage cervical cancer in Bangladesh.
    BMC Cancer. 2021;21:670.
    PubMed     Abstract available

  78. AKHAVAN S, Alibakhshi A, Parsapoor M, Alipour A, et al
    Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    BMC Cancer. 2021;21:667.
    PubMed     Abstract available

  79. ZOU D, Guo M, Zhou Q
    A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    BMC Cancer. 2021;21:661.
    PubMed     Abstract available

    May 2021
  80. DENG ZM, Dai FF, Zhou Q, Cheng YX, et al
    Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.
    BMC Cancer. 2021;21:583.
    PubMed     Abstract available

  81. CHEN HH, Meng WY, Li RZ, Wang QY, et al
    Potential prognostic factors in progression-free survival for patients with cervical cancer.
    BMC Cancer. 2021;21:531.
    PubMed     Abstract available

  82. LI W, Xiong L, Zhu Q, Lu H, et al
    Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    BMC Cancer. 2021;21:484.
    PubMed     Abstract available

    April 2021
  83. FENG Y, Wang Y, Xie Y, Wu S, et al
    Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    BMC Cancer. 2021;21:450.
    PubMed     Abstract available

  84. LEE F, Bula A, Chapola J, Mapanje C, et al
    Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    BMC Cancer. 2021;21:428.
    PubMed     Abstract available

  85. LI Y, Chen Z, Wang X, Li X, et al
    Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
    BMC Cancer. 2021;21:442.
    PubMed     Abstract available

  86. LIU H, Ye X, Li D, Yao Q, et al
    Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.
    BMC Cancer. 2021;21:421.
    PubMed     Abstract available

  87. MA D, Pan Z, Chang Q, Zhang JJ, et al
    KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    BMC Cancer. 2021;21:377.
    PubMed     Abstract available

  88. TISLER A, Ojavee SE, Veerus P, Soodla P, et al
    Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
    BMC Cancer. 2021;21:350.
    PubMed     Abstract available

    March 2021
  89. ZHANG SW, Luo RZ, Sun XY, Yang X, et al
    Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    BMC Cancer. 2021;21:332.
    PubMed     Abstract available

  90. SHARMIN S, Zohura FT, Islam MS, Shimonty A, et al
    Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    BMC Cancer. 2021;21:289.
    PubMed     Abstract available

  91. GAETE S, Auguste A, Bhakkan B, Peruvien J, et al
    Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    BMC Cancer. 2021;21:281.
    PubMed     Abstract available

  92. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    PubMed     Abstract available

  93. JU Z, Guo W, Gu S, Zhou J, et al
    CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
    BMC Cancer. 2021;21:243.
    PubMed     Abstract available

  94. ARARSA T, Tadele N, Ayalew Y, Gela D, et al
    Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
    BMC Cancer. 2021;21:224.
    PubMed     Abstract available

    February 2021
  95. YANG E, Huang S, Ran X, Huang Y, et al
    The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    BMC Cancer. 2021;21:203.
    PubMed     Abstract available

  96. CHU G, Liu X, Yu W, Chen M, et al
    Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study.
    BMC Cancer. 2021;21:133.
    PubMed     Abstract available

  97. GOUY S, Seebacher V, Chargari C, Terroir M, et al
    False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
    BMC Cancer. 2021;21:135.
    PubMed     Abstract available

  98. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
    Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
    BMC Cancer. 2021;21:110.
    PubMed     Abstract available

  99. CHI RA, van der Watt P, Wei W, Birrer MJ, et al
    Inhibition of Kpnbeta1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
    BMC Cancer. 2021;21:106.
    PubMed     Abstract available

    January 2021
  100. DEL MORAL-HERNANDEZ O, Hernandez-Sotelo D, Alarcon-Romero LDC, Mendoza-Catalan MA, et al
    TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    BMC Cancer. 2021;21:39.
    PubMed     Abstract available

    December 2020
  101. BAO H, Wang L, Brown M, Zhang M, et al
    A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.
    BMC Cancer. 2020;20:1191.
    PubMed     Abstract available

    November 2020
  102. TAKEKUMA M, Takahashi F, Mabuchi S, Kudaka W, et al
    Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.
    BMC Cancer. 2020;20:1169.
    PubMed     Abstract available

  103. CAI L, Hu C, Yu S, Liu L, et al
    Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
    BMC Cancer. 2020;20:1133.
    PubMed     Abstract available

  104. PITTALIS C, Panteli E, Schouten E, Magongwa I, et al
    Breast and cervical cancer screening services in Malawi: a systematic review.
    BMC Cancer. 2020;20:1101.
    PubMed     Abstract available

  105. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
    Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
    BMC Cancer. 2020;20:1097.
    PubMed     Abstract available

  106. BANU N, Riera-Leal A, Haramati J, Ortiz-Lazareno PC, et al
    B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
    BMC Cancer. 2020;20:1083.
    PubMed     Abstract available

    October 2020
  107. LIU J, Li Y, Chen X, Xu X, et al
    Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
    BMC Cancer. 2020;20:1029.
    PubMed     Abstract available

    September 2020
  108. GESINK MP, Chamberlain RM, Mwaiselage J, Kahesa C, et al
    Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
    BMC Cancer. 2020;20:939.
    PubMed     Abstract available

  109. CHEN M, Wang H, Liang Y, Hu M, et al
    Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2020;20:926.
    PubMed     Abstract available

  110. CHEN S, Li K
    HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    BMC Cancer. 2020;20:924.
    PubMed     Abstract available

    July 2020
  111. TESFAW G, Ahmed Y, Gedefaw L, Dube L, et al
    Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia.
    BMC Cancer. 2020;20:706.
    PubMed     Abstract available

  112. LEE SY, Chae DK, Lee SH, Lim Y, et al
    Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    BMC Cancer. 2020;20:694.
    PubMed     Abstract available

  113. AARNIO R, Ostensson E, Olovsson M, Gustavsson I, et al
    Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    BMC Cancer. 2020;20:645.
    PubMed     Abstract available

    June 2020
  114. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
    Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
    BMC Cancer. 2020;20:577.
    PubMed     Abstract available

  115. ITO M, Kodaira T, Koide Y, Okuda T, et al
    Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    BMC Cancer. 2020;20:540.
    PubMed     Abstract available

  116. VAN DE LAAR RLO, Hofhuis W, Duijnhoven RG, Polinder S, et al
    Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    BMC Cancer. 2020;20:539.
    PubMed     Abstract available

    May 2020
  117. BRUNO MT, Scalia G, Cassaro N, Boemi S, et al
    Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
    BMC Cancer. 2020;20:444.
    PubMed     Abstract available

  118. ZHANG J, Zhang D, Yang Z, Wang X, et al
    The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    BMC Cancer. 2020;20:443.
    PubMed     Abstract available

  119. GUO HT, Bi XH, Lei T, Lv X, et al
    Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    BMC Cancer. 2020;20:441.
    PubMed     Abstract available

  120. CHEN P, Jiao L, Ren F, Wang DB, et al
    Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    BMC Cancer. 2020;20:423.
    PubMed     Abstract available

  121. EJEGOD DM, Lagheden C, Bhatia R, Pedersen H, et al
    Clinical validation of full genotyping CLART(R) HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    BMC Cancer. 2020;20:396.
    PubMed     Abstract available

    April 2020
  122. SILVA NNT, Santos ACS, Nogueira VM, Carneiro CM, et al
    3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
    BMC Cancer. 2020;20:323.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.